Paper7541555
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
Yu CL and 6 others. Science, 1995. Cited by 829 papers, by iCite.
Cite this record
ConductScience Library. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Papers, record 7541555. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7541555
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| DNA | Major topic |
| DNA-Binding Proteins | Major topic |
| Interleukin-6 | Major topic |
| Oncogene Protein pp60(v-src) | Major topic |
| Signal Transduction | Major topic |
| Trans-Activators | Major topic |
| Animals | |
| Base Sequence | |
| Cell Line, Transformed | |
| Growth Inhibitors | |
| Interferon-gamma | |
| Leukemia Inhibitory Factor | |
| Lymphokines | |
| Mice | |
| Molecular Sequence Data | |
| Phosphorylation | |
| Phosphotyrosine | |
| STAT3 Transcription Factor | |
| Tyrosine |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK034171 | NIDDK NIH HHS | United States | R01DK034171 | PubMed and NIH | NIH RePORTER |
| CA55652 | NCI NIH HHS | United States | R01CA055652 | PubMed and NIH | NIH RePORTER |
| DK34171 | NIDDK NIH HHS | United States | R01DK034171 | PubMed and NIH | NIH RePORTER |
| R37DK034171 | NIH | NIH RePORTER |
Cited by379
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 829 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42547268 | TNK1 is a targetable JAK-independent driver of STAT signaling and inflammation. | Genes Dev | 2026 | https://conductscience.org/library/papers/42547268 | PubMed |
| 42004951 | JAK inhibition in PD-1 immunotherapy and tumor microenvironment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42004951 | PubMed |
| 41563447 | Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41563447 | PubMed |
| 41041277 | Decoding Sepsis: Unraveling Key Signaling Pathways for Targeted Therapies. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/41041277 | PubMed |
| 40948745 | PKM2 orchestrates tumor progression via metabolic reprogramming and MDSCs-mediated immune suppression in the tumor microenvironment. | Front Immunol | 2025 | https://conductscience.org/library/papers/40948745 | PubMed |
| 40799818 | Recombinant human growth hormone and brain neoplasm association: a pharmacovigilance and Mendelian randomization analysis based on US FAERS, Japanese JADER, and Canadian CVARD. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40799818 | PubMed |
| 40492515 | Lactate-Activated GPR132-Src Signal Induces Macrophage Senescence and Aggravates Atherosclerosis Under Diabetes. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40492515 | PubMed |
| 39924517 | Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39924517 | PubMed |
| 39756576 | Reconceptualizing Endothelial-to-mesenchymal transition in atherosclerosis: Signaling pathways and prospective targeting strategies. | J Adv Res | 2025 | https://conductscience.org/library/papers/39756576 | PubMed |
| 38977663 | Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38977663 | PubMed |
| 38495094 | JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38495094 | PubMed |
| 38357786 | TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38357786 | PubMed |
| 38339245 | Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38339245 | PubMed |
| 38185635 | Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38185635 | PubMed |
| 38102641 | PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/38102641 | PubMed |
| 37672248 | 2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity. | Am J Physiol Endocrinol Metab | 2023 | https://conductscience.org/library/papers/37672248 | PubMed |
| 37372319 | JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37372319 | PubMed |
| 37120696 | Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities. | Oncogene | 2023 | https://conductscience.org/library/papers/37120696 | PubMed |
| 37033974 | PlGF/FLT-1 deficiency leads to reduced STAT3-C/EBPβ signaling and aberrant polarization in decidual macrophages during early spontaneous abortion. | Front Immunol | 2023 | https://conductscience.org/library/papers/37033974 | PubMed |
| 36907523 | A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. | Gastroenterology | 2023 | https://conductscience.org/library/papers/36907523 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SRC | 6714 | PubTator's text mining | https://conductscience.org/library/genes/6714 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7541555
GET https://conductscience.org/api/papers/v1/7541555/cited_by?page=2